通过抑制谷氨酸羧肽酶II（GCPII）调节谷氨酸合成：一种治疗中枢和外周神经系统疾病的有效方法。 - Suppr | 超能文献

Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disorders.

作者信息

Cavaletti Guido, Slusher Barbara

出版信息

Curr Med Chem. 2012;19(9):1259-60. doi: 10.2174/092986712799462577.

DOI:10.2174/092986712799462577

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disorders.通过抑制谷氨酸羧肽酶II（GCPII）调节谷氨酸合成：一种治疗中枢和外周神经系统疾病的有效方法。

Curr Med Chem. 2012;19(9):1259-60. doi: 10.2174/092986712799462577.

2

The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II.谷氨酸在糖尿病和化疗诱导的周围神经病中的作用及其受谷氨酸羧肽酶 II 的调节。

Curr Med Chem. 2012;19(9):1261-8. doi: 10.2174/092986712799462694.

3

Glutamate in CNS neurodegeneration and cognition and its regulation by GCPII inhibition.CNS 神经退行性变和认知中的谷氨酸及其受 GCPII 抑制的调节。

Curr Med Chem. 2012;19(9):1335-45. doi: 10.2174/092986712799462649.

4

Tissue distribution of glutamate carboxypeptidase II (GCPII) with a focus on the central and peripheral nervous system.谷氨酸羧肽酶 II（GCPII）在中枢和外周神经系统中的组织分布。

Curr Med Chem. 2012;19(9):1277-81. doi: 10.2174/092986712799462568.

5

Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.谷氨酸羧肽酶 II（GCPII）抑制剂的构效关系。

Curr Med Chem. 2012;19(9):1282-94. doi: 10.2174/092986712799462658.

6

Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.阻断谷氨酸羧肽酶II可抑制谷氨酸兴奋性毒性并调节实验性自身免疫性脑脊髓炎中的免疫反应。

FEBS J. 2016 Sep;283(18):3438-56. doi: 10.1111/febs.13816. Epub 2016 Aug 11.

7

The role of glutamate signaling in pain processes and its regulation by GCP II inhibition.谷氨酸信号在疼痛过程中的作用及其受 GCP II 抑制的调节。

Curr Med Chem. 2012;19(9):1323-34. doi: 10.2174/092986712799462630.

8

Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.谷氨酸羧肽酶抑制减轻大鼠化疗引起的外周神经毒性的严重程度。

Neurotox Res. 2010 May;17(4):380-91. doi: 10.1007/s12640-009-9114-1. Epub 2009 Sep 15.

9

[The activation of the cholinergic innervation in the treatment of diseases of the peripheral and central nervous system].[胆碱能神经支配在周围和中枢神经系统疾病治疗中的激活作用]

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(6):91-8.

10

Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.谷氨酸羧肽酶II的结构，一种在神经元损伤和前列腺癌中的药物靶点。

EMBO J. 2006 Mar 22;25(6):1375-84. doi: 10.1038/sj.emboj.7600969. Epub 2006 Feb 9.

引用本文的文献

1

Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy.树状高分子介导的靶向递送减轻谷氨酸兴奋性毒性并改善脑瘫兔模型的运动功能。

J Control Release. 2023 Jun;358:27-42. doi: 10.1016/j.jconrel.2023.04.017. Epub 2023 Apr 26.

2

Dendrimer-Conjugated Glutamate Carboxypeptidase II Inhibitor Restores Microglial Changes in a Rabbit Model of Cerebral Palsy.树枝状聚合物偶联谷氨酸羧肽酶II抑制剂可恢复脑瘫兔模型中的小胶质细胞变化。

Dev Neurosci. 2023;45(5):268-275. doi: 10.1159/000530389. Epub 2023 Mar 29.

3

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.靶向谷氨酸羧肽酶II的复合抑制剂设计：效应官能团的重要性

FEBS J. 2016 Jan;283(1):130-43. doi: 10.1111/febs.13557. Epub 2015 Nov 5.